Posted by Reuters: Business News on November 22, 2011
(Reuters) – Pfizer Inc agreed to buy privately held biopharmaceutical company Excaliard Pharmaceuticals for an undisclosed sum, to gain access to Excaliard’s experimental skin scarring drug.
Posted by Reuters: Business News on October 28, 2011
(Reuters) – Merck & Co’s quarterly profit and sales beat forecasts as strong demand for the company’s diabetes and asthma drugs offset a sharp decline for its Remicade arthritis drug.
Posted by Reuters: Business News on September 17, 2010
BOSTON (Reuters) – Shares of Arena Pharmaceuticals Inc plunged anew on Friday as the company blamed a lack of understanding on the part of U.S. reviewers for their failure to recommend approval of its experimental obesity drug.
Posted by Reuters: Business News on March 4, 2010
NEW YORK (Reuters) – Bristol-Myers Squibb Co set a baseline for profits in 2013 as it provided investors their first glimpse of life after Plavix, the world’s second-bestselling drug.
